Current GLP-1 analogues approved for use in the United States and the European Union include: exenatide twice daily [4], exenatide once weekly [5], liraglutide once daily [6], lixisenatide once daily (not approved in the U.S.) [7] and albiglutide once weekly [8], which are all delivered through subcutaneous injection and initial dose titration is required to improve gastrointestinal tolerance
If someone feels stressed, depressed, or anxious while on the medication, this can affect sexual desire and performance
Prior authorization requirements may need to be met before coverage begins
Medical supervision included in our programs provides comprehensive initial evaluation and ongoing monitoring, dose adjustments based on your response and tolerance, side effect management and troubleshooting, lab work coordination when needed, and nutrition and lifestyle guidance
CJC-1295 DAC (5 mg Vial): Advanced / Aggressive Approach (1 mL = 5 mg/mL) Reconstitute: Add 1.0 mL bacteriostatic water to one 5 mg vial higher concentration 5 mg/mL
:max_bytes(150000):strip_icc():focal(749x0:751x2)/oatzempic-040124-5-c01290c2c2d8468c9fcfa1195527e52a.jpg)
